Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

PLCRC-MEDOCC group, Schraa, S. J., van Rooijen, K. L., van der Kruijssen, D. E. W., Rubio Alarcón, C., Phallen, J., Sausen, M., Simmons, J., Coupé, V. M. H., van Grevenstein, W. M. U., Elias, S., Verkooijen, H. M., Laclé, M. M., Bosch, L. J. W., van den Broek, D., Meijer, G. A., Velculescu, V. E., Fijneman, R. J. A., Vink, G. R. & Koopman, M., 20-Aug-2020, In: BMC Cancer. 20, 1, 10 p., 790.

Research output: Contribution to journal › Article › Academic › peer-review

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Qiu, S-Q., van Rooijen, J., Nienhuis, H. H., van der Vegt, B., Timmer-Bosscha, H., van Leeuwen-Stok, E., Walenkamp, A. M. E., van Deurzen, C. H. M., de Bock, G. H., de Vries, E. G. E. & Schroder, C. P., 18-Mar-2020, In: Breast cancer research. 22, 1, 10 p., 30.

Research output: Contribution to journal › Article › Academic › peer-review

Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: A population-based study focusing on the elderly

van Rooijen, J. M., de Munck, L., Teeuwen, G. M., de Graaf, J. C., Jansman, F. G., Boers, J. E. & Siesling, S., Feb-2016, In: Anti-Cancer Drugs. 27, 2, p. 127-32 6 p.

Research output: Contribution to journal › Article › Academic › peer-review

Immunotherapeutic options on the horizon in breast cancer treatment

van Rooijen, J. M., Stutvoet, T. S., Schröder, C. P. & de Vries, E. G. E., Dec-2015, In: Pharmacology & Therapeutics. 156, p. 90-101 12 p.

Research output: Contribution to journal › Review article › peer-review